You just read:

Tolero Pharmaceuticals to Highlight Clinical Data Evaluating Investigational Agent Alvocidib in Patients with Newly Diagnosed AML at EHA 2019

News provided by

Tolero Pharmaceuticals, Inc.

May 16, 2019, 09:45 ET